Similarities and differences of dietary and other determinants of iodine status in pregnant women from three European birth cohorts by Dineva, Mariana et al.
1 
 
Similarities and differences of dietary and other determinants of iodine status in 1 
pregnant women from three European birth cohorts 2 
 3 
Mariana Dineva, Margaret P. Rayman, Deborah Levie, Mònica Guxens, Robin P. Peeters, 4 
Jesus Vioque, Llúcia González, Mercedes Espada, Jesús Ibarluzea, Jordi Sunyer, Tim I.M. 5 
Korevaar, Sarah C. Bath 6 
 7 
Affiliations  8 
Department of Nutritional Sciences, Faculty of Health and Medical Sciences, University of 9 
Surrey, Guildford, United Kingdom (MD, MPR, and SCB); The Generation R Study Group, 10 
Erasmus University Medical Centre, Rotterdam, The Netherlands (DL and TIMK); 11 
Department of Internal Medicine, Academic Centre For Thyroid Diseases, Erasmus 12 
University Medical Centre, Rotterdam, The Netherlands (DL, RPP, and TIMK); Department 13 
of Child and Adolescent Psychiatry/Psychology, Erasmus University Medical Centre–Sophia 14 
Children’s Hospital, Rotterdam, The Netherlands (DL and MG); ISGlobal, Barcelona, Spain 15 
(DL, MG, and JS); Pompeu Fabra University, Barcelona, Spain (DL, MG, and JS); Spanish 16 
Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de 17 
Salud Carlos III, Madrid, Spain (DL, MG, JV, JI, and JS); Nutritional Epidemiology Unit, 18 
Miguel Hernández University, ISABIAL-FISABIO, Alicante, Spain (JV); Epidemiology and 19 
Environmental Health Joint Research Unit, FISABIO-Universitat Jaume I-Universitat de 20 
València, Valencia, Spain (LG); Predepartamental Unit of Medicine, University Jaume I, 21 
Castelló, Spain (LG); Departamento de Salud del Gobierno Vasco, Public Health Laboratory 22 
of Bilbao, Basque Government, Derio, Spain (ME); BIODONOSTIA Health Research 23 
Institute, Donostia – San Sebastián, Spain (ME and JI); Departamento de Salud del Gobierno 24 
Vasco, Subdirección de Salud Pública de Guipúzcoa, Donostia – San Sebastián, Spain (JI); 25 
2 
 
Facultad de Psicología, University of the Basque Country UPV/EHU, Donostia - San 26 
Sebastián, Spain (JI); and Hospital del Mar Research Institute (IMIM), Barcelona, Spain (JS). 27 
 28 
Corresponding author 29 
Sarah C. Bath, Department of Nutritional Sciences, Faculty of Health and Medical Sciences, 30 
University of Surrey, Guildford GU2 7XH, United Kingdom. E-mail: s.bath@surrey.ac.uk. 31 
Telephone: +44 (0)1483 683631.  32 
 33 
Acknowledgements  34 
EUthyroid project: This project has received funding from the European Union´s Horizon 35 
2020 research and innovation programme under grant agreement No 634453. 36 
ALSPAC: We are extremely grateful to all the families who took part in this study, 37 
the midwives for their help in recruiting them, and the whole ALSPAC team, which includes 38 
interviewers, computer and laboratory technicians, clerical workers, research scientists, 39 
volunteers, managers, receptionists and nurses. The UK Medical Research Council and 40 
Wellcome (Grant ref: 102215/2/13/2) and the University of Bristol provide core support for 41 
ALSPAC. This publication is the work of the authors and Dr Bath will serve as a guarantor 42 
for the contents of this paper. ALSPAC data collection is funded from a wide range of 43 
sources, a comprehensive list of which is available on the ALSPAC website 44 
(http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). The 45 
existing iodine measurements in ALSPAC were funded from (i) the NUTRIMENTHE 46 
project, which received a research grant from the European Community’s 7th Framework 47 
Programme (FP7/2008–2013) under grant agreement 212652; and (ii) a Ph.D. studentship 48 
that was funded by Wassen International and the Waterloo Foundation (2009–2012). 49 
3 
 
We would like to thank Dr Pauline Emmett for helping with the dietary analysis of the 50 
ALSPAC food frequency questionnaire.  51 
Generation R: The Generation R Study is conducted by the Erasmus Medical Center 52 
in close collaboration with the Faculty of Social Sciences of the Erasmus University 53 
Rotterdam, the Municipal Health Service Rotterdam area, Rotterdam, and the Stichting 54 
Trombosedienst & Artsenlaboratorium Rijnmond (STAR-MDC), Rotterdam. The Generation 55 
R Study is supported by the Erasmus Medical Center, Rotterdam, the Erasmus University 56 
Rotterdam, the Netherlands Organization for Health Research and Development (ZonMw), 57 
the Netherlands Organization for Scientific Research (NWO), the Ministry of Health, 58 
Welfare and Sport. A grant from the Sophia Children’s Hospital Research Funds supports the 59 
neurodevelopmental work on thyroid; Robin P. Peeters is supported by a clinical fellowship 60 
from ZonMw, project number 90700412. 61 
INMA: This study was funded by grants from UE (FP7-ENV-2011 cod 282957 and 62 
HEALTH.2010.2.4.5-1) and Spain: Instituto de Salud Carlos III (Red INMA G03/176; 63 
CB06/02/0041; FIS-FEDER: PI041436, PI05/1079, PI06/0867, PI081151, FIS-and 64 
PS09/00090, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/2032, PI14/00891, 65 
PI14/01687, and PI16/1288; Miguel Servet-FEDER CP11/00178, CP15/00025, and 66 
CPII16/00051, MS13/00054), Generalitat Valenciana: FISABIO (UGP 15-230, UGP-15-244, 67 
and UGP-15-249), Generalitat de Catalunya-CIRIT 1999SGR 00241, Fundació La marató de 68 
TV3 (090430), Department of Health of the Basque Government (2005111093 and 69 
2009111069), and the Provincial Government of Gipuzkoa (DFG06/004 and DFG08/001). 70 
 71 
Abbreviations 72 
ALSPAC, the Avon Longitudinal Study of Parents and Children 73 
BMI, body mass index 74 
4 
 
CI, confidence interval 75 
CRM, certified reference material 76 
EXP, exponentiation 77 
FFQ, food frequency questionnaire 78 
INMA, INfancia y Medio Ambiente 79 
IQ, intelligence quotient 80 
RSD, relative standard deviation 81 
SD, standard deviation  82 
SEE, standard error of estimate  83 
SFFQ, semi-quantitative food frequency questionnaire 84 
UI/Creat, urinary iodine-to-creatinine ratio 85 
UIC, urinary iodine concentration 86 
UK, United Kingdom 87 
WHO, World Health Organisation  88 
5 
 
Abstract  89 
Purpose: As a component of thyroid hormones, adequate iodine intake is essential during 90 
pregnancy for fetal neurodevelopment. Across Europe, iodine deficiency is common in 91 
pregnancy but data are lacking on the predictors of iodine status at this life stage. We 92 
therefore aimed to explore determinants of iodine status during pregnancy in three European 93 
populations of differing iodine status. 94 
Methods: Data were from 6566 pregnant women from three prospective population-based 95 
birth cohorts from the United Kingdom (ALSPAC, n=2852), Spain (INMA, n=1460), and the 96 
Netherlands (Generation R, n=2254). Urinary iodine-to-creatinine ratio (UI/Creat, µg/g) was 97 
measured in spot-urine samples in pregnancy (≤18-weeks gestation). Maternal dietary intake, 98 
categorised by food groups (g/day) was estimated from food-frequency questionnaires 99 
(FFQs). Multivariable regression models used dietary variables (energy-adjusted) and 100 
maternal characteristics as predictors of iodine status. 101 
Results: Median UI/Creat in pregnant women of ALSPAC, INMA and Generation R was 102 
121, 151, and 210 µg/g, respectively. Maternal age was positively associated with UI/Creat in 103 
all cohorts (P<0.001), while UI/Creat varied by ethnicity only in Generation R (P<0.05). Of 104 
the dietary predictors, intake of milk and dairy products (per 100 g/day) was positively 105 
associated with UI/Creat in all cohorts [ALSPAC (B=3.73, P<0.0001); INMA (B=6.92, 106 
P=0.002); Generation R (B=2.34, P=0.001)]. Cohort-specific dietary determinants positively 107 
associated with UI/Creat included fish and shellfish in ALSPAC and INMA, and eggs and 108 
cereal/cereal products in Generation R. 109 
Conclusions: The cohort-specific dietary determinants probably reflect not only dietary 110 
habits but iodine-fortification policies, hence public-health interventions to improve iodine 111 
intake in pregnancy need to be country-specific. 112 
Keywords: iodine, pregnancy, diet, determinants, milk and dairy products, ALSPAC  113 
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Introduction  114 
Iodine is an essential component of the thyroid hormones which are important for optimal 115 
fetal and early postnatal neurodevelopment [1, 2]. Mild-to-moderate maternal iodine 116 
deficiency in early pregnancy has been associated with suboptimal offspring cognitive 117 
outcomes [3–7]. The early stages of pregnancy mark the beginning of crucial fetal brain 118 
development processes such as neuron proliferation, migration and differentiation [8]. 119 
Though these early processes are thyroid hormone-dependent, the fetal thyroid gland is not 120 
fully functional until 18-20 weeks, highlighting the importance of thyroid hormone supply 121 
from the mother. In this critical early period, the mother therefore needs sufficient iodine 122 
intake to maintain optimal thyroid function [1]. As a result of the increased demand for 123 
thyroid hormones and other physiological changes associated with pregnancy, pregnant 124 
women have a higher iodine requirement than the general population, putting them at greater 125 
risk of deficiency [9, 10].  126 
As more than 90% of the dietary iodine absorbed is excreted by the kidneys, urinary 127 
iodine concentration (UIC) is considered to be a good estimate of recent iodine intake at the 128 
population level [11]. In pregnant populations, iodine sufficiency is defined by a median UIC 129 
in the range of 150-249 µg/L, corresponding to the iodine intake of 250 µg/day recommended 130 
by the World Health Organisation (WHO) [12]. 131 
Determining the main food sources of iodine in pregnancy is essential so that 132 
pregnant women can be given information on how to achieve adequate iodine nutrition. 133 
Although good food sources of iodine, such as milk, eggs, fish, and, in some countries, 134 
iodised salt, are well-known, the consumption patterns of these foods vary between and 135 
within populations, as does their iodine content (i.e., as a result of seasonal variation, 136 
agricultural practices, and differences in iodine content of soil and water) [13, 14]. 137 
Consequently, some variation in the importance of different iodine food sources to population 138 
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iodine status is expected between countries, hence universal dietary recommendations to 139 
increase iodine intake are unlikely to be appropriate.  140 
Considering the negative consequences of iodine deficiency in pregnancy and the fact 141 
that many pregnant women worldwide are still iodine-deficient [15], achieving adequate 142 
iodine status in the pregnant population is of public-health importance. Data are, however, 143 
lacking on the determinants of iodine status in pregnancy in both deficient and sufficient 144 
areas; knowledge of such factors would help to identify women likely to have low iodine 145 
status.  146 
This study aimed to explore the determinants of iodine status during early pregnancy 147 
in three European populations of differing iodine status. The objectives of the study were: (i) 148 
to establish whether iodine status during early pregnancy is associated with maternal socio-149 
demographic, anthropometric, lifestyle factors, and pregnancy characteristics; (ii) to 150 
determine how maternal iodine status is influenced by dietary intake during pregnancy; (iii) 151 
to identify similarities and differences in the main determinants of iodine status between 152 
deficient and sufficient pregnant populations. 153 
 154 
Methods 155 
Study population 156 
Data from three prospective population-based birth cohorts were used: (i) the Avon 157 
Longitudinal Study of Parents and Children (ALSPAC) in the United Kingdom (UK) [16, 158 
17], (ii) Generation R in the Netherlands [18], and (iii) INfancia y Medio Ambiente (INMA) 159 
in Spain [19]. In ALSPAC, 14 541 pregnant women living in the former Avon area in the 160 
South-West of England, with an expected delivery date between 1st April 1991 and 31st 161 
December 1992, were recruited. The study website contains details of all the data that are 162 
available through a fully searchable data dictionary and variable search tool [20].  In 163 
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Generation R, 9 778 mothers residing in Rotterdam with an expected delivery date from April 164 
2002 to January 2006 were enrolled in the study. In total, 2 150 pregnant women were 165 
recruited as part of the INMA Project from three regions in Spain (Valencia, Sabadell and 166 
Gipuzkoa), in the period of November 2003 to January 2008. 167 
 168 
Ethics 169 
Ethical approval was obtained prior to recruitment from a number of bodies: the ALSPAC 170 
Ethics and Law Committee and the Local Research Ethics Committees (ALSPAC), the 171 
Medical Ethical Committee of the Erasmus Medical Centre (Generation R), the Ethical 172 
Committee of the Municipal Institute of Medical Investigation and the ethical committees of 173 
the hospitals involved in the studies (INMA). All participating women provided informed 174 
consent.  175 
 176 
Selection criteria for the current study 177 
Women were selected for the current study if they had at least one pre-existing measure of 178 
urinary iodine concentration in pregnancy [4, 21, 22] or urine samples available for iodine 179 
measurement, provided that the child had a measure of intelligence quotient (IQ) for 180 
ALSPAC and Generation R. In INMA, iodine was measured in all women with additional 181 
urine samples available, irrespective of child-IQ data.  182 
Women with multiple pregnancies, in-vitro fertilisation, known thyroid disease, 183 
and/or use of thyroid-related medication were excluded (Fig. 1). We restricted analyses to 184 
measures from early pregnancy, the most critical time for iodine-dependent brain 185 
development [2, 23], hence for this study, only samples collected  ≤ 18 weeks’ gestation were 186 
included.  187 
 188 
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Iodine measurements  189 
Urinary iodine concentration (UIC, µg/L) was measured in spot-urine samples collected at a 190 
median (25-75th percentile) gestational age of 11.0 (8.0-15.0) weeks in ALSPAC, 13.1 (12.1-191 
14.6) weeks in Generation R, and 13.0 (12.4-13.9) weeks in INMA. Gestational week was 192 
established using ultrasound examination (Generation R and INMA) or the date of the last 193 
menstrual period (ALSPAC). To adjust for variation in intra- and inter-individual daily 194 
hydration status [24–27], iodine concentration was corrected by dividing by urinary 195 
creatinine concentration to give the iodine-to-creatinine ratio (UI/Creat, µg/g). Correcting 196 
UIC by use of urinary creatinine concentration reduces intra-individual variation [25], 197 
especially in cohorts of the same sex and age-range [i.e., our cohorts were all women of 198 
childbearing age (15-44 years)]. The iodine-to-creatinine ratio has previously been used in all 199 
three cohorts [4, 7, 21].  200 
In each cohort we reported both the median (25-75th percentile) UIC (µg/L) and 201 
UI/Creat (µg/g). The percentage with UI/Creat <150 µg/g was also reported; this cut-off was 202 
informed by the WHO threshold for adequacy in pregnancy (a median UIC ≥150 µg/L) [12] 203 
and when corrected for creatinine concentration, has been used in previous research [4, 6, 7].  204 
 205 
Laboratory analysis 206 
Urinary creatinine concentration was determined by the Jaffe rate method in all 207 
cohorts. Urinary iodine concentration was determined as previously described in detail [4, 208 
22]; a brief description follows. 209 
ALSPAC: Urinary iodine concentration was measured as 127I at the Trace Element 210 
Unit, Southampton General Hospital, on a dynamic reaction cell inductively-coupled plasma 211 
mass spectrometer (NexION 300D Perkin-Elmer, Beaconsfield). The accuracy of the results 212 
was verified using the certified reference material (CRM) Seronorm urine Levels 1 and 2 213 
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(Nycomed, Norway), and accuracy was also monitored by measurement of EQUIP samples at 214 
regular intervals throughout the analysis. Within-run precision gave a relative standard 215 
deviation (RSD) of 0.8% at 42 µg/L, 2.5% at 84 µg/L, 0.6% at 149 µg/L, and 2.0% at 297 216 
µg/L. Between-run precision was 8.7% RSD at 42 µg/L, 6.5% at 84 µg/L, 7.2% at 149 µg/L, 217 
and 6.8% at 297 µg/L. 218 
Generation R: Urinary iodine concentration was measured in Radboud University 219 
Medical Centre, Nijmegen, the Netherlands, by the Sandell-Kolthoff method. Iodine 220 
calibration was performed using the CRM Seronorm urine Levels 1 and 2 (Nycomed, 221 
Norway) and four EQUIP samples that were certified for urinary iodine concentration 222 
(Centers for Disease Control and Prevention, USA). At a level of 216 µg/L the within-assay 223 
precision was 5.1% RSD and the between-assay precision was 14.3% RSD (n= 30).   224 
INMA: Urinary iodine concentration was measured at the Public Health Laboratory 225 
Standards, Basque Government Department of Health, Spain (Acreditation LE/1108 with ISO 226 
15189 for Clinical Laboratories, National Acreditation Entity), using a paired-ion reversed-227 
phase, high-performance liquid chromatography with electrochemical detection at a silver 228 
working electrode (Waters Chromatography, Milford, MA). The accuracy of the results was 229 
verified using the CRM Seronorm urine Levels 1 and 2 (Nycomed, Norway) and internal 230 
quality control samples. Within-run precision was 4.5% RSD at 50 μg/L, 3.2% at 100 μg/L, 231 
and 2·0% at 300 μg/L. Between-run precision was 7.9% RSD at 50 μg/L, 3.5% at 100 μg/L, 232 
and 2.5 % at 300 μg/L. 233 
In ALSPAC, there was concern that some urine samples had been contaminated by 234 
the use of iodine-containing test strips [28], and therefore samples with UIC >500 µg/L 235 
and/or UI/Creat >700 µg/g were excluded (n=412, 11.8%). These cut-offs were based on 236 
previous information from ALSPAC and from other studies of UK pregnant women [4, 29, 237 
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30]. Some ALSPAC women had multiple urine samples and in cases where one sample was 238 
contaminated, the results from the next available uncontaminated sample were used (n=50).  239 
 240 
Dietary assessment  241 
Maternal diet in all cohorts was assessed using a food frequency questionnaire (FFQ). This 242 
was administered in late pregnancy in ALSPAC (at 32 weeks) and in early pregnancy in 243 
Generation R and INMA (at the same time as urine sampling). The FFQ was unquantified in 244 
ALSPAC, but was semi-quantitative (SFFQ) in Generation R and INMA. The FFQ was self-245 
administered in ALSPAC and Generation R, and administered by trained interviewers in 246 
INMA. 247 
ALSPAC: Detailed information about the design of the questionnaire can be found 248 
elsewhere [31, 32]. Briefly, women were asked to indicate how frequently “nowadays” they 249 
consumed 43 food groups and individual foods with five predefined frequency categories, 250 
ranging from “never or rarely” to “more than once a day”. Portion sizes were not included in 251 
the questionnaire.  252 
Generation R: SFFQ in Generation R represented an adapted version of a validated 253 
SFFQ in elderly subjects [33]. In summary, it contained a list of 293 foods and asked about 254 
frequency of consumption in the past three months, mostly therefore reflecting the first 255 
trimester. Questions about portion size, estimated using food photographs or Dutch 256 
household measures, methods of preparation, and additions to foods were also included [3, 257 
34]. The food list had previously been reduced to 17 main food groups [35], based on the 258 
European Prospective Investigation into Cancer and Nutrition SOFT classification (EPIC-259 
SOFT) [36].  260 
INMA: SFFQ was based on an expanded adaptation of a 61-item SFFQ by Willet and 261 
colleagues [37] that was developed and validated [38, 39]. To summarise, women were asked 262 
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how often, on average, they had consumed a specified standard portion of 100 food items in 263 
early pregnancy (since their last menstrual period until the time of the interview at ~12 264 
weeks), using nine frequency categories, ranging from “never or less than once a month” to 265 
“six or more times per day”.  266 
For the current study, in each cohort, food intake (g/day) was calculated by 267 
multiplying the frequency of consumption by an average standard portion (for the ALSPAC 268 
FFQ) or a specified portion (for the SFFQ in Generation R and INMA) of that food. Foods 269 
were then classified into food groups and the amounts of individual food items consumed 270 
were summed accordingly. To facilitate comparison between cohorts, the classification of 271 
food groups used in Generation R [36] was used as a template. This required the formation of 272 
new food groups in ALSPAC, while the pre-existing food groups were used in Generation R 273 
and INMA, with some minor modifications to make them comparable. The definitions of 274 
food groups in the individual cohorts are shown in Supplemental Table 1. Separate 275 
information about the consumption of table salt and use of iodine-fortified table salt was 276 
collected only in the INMA cohort.  277 
 278 
Iodine supplement use 279 
Detailed data on the use of potassium iodide and/or iodine-containing multivitamin/mineral 280 
supplements during pregnancy were collected only in INMA. For this analysis, we used data 281 
on iodine supplements from pre-pregnancy until the end of the first trimester, expressed as 282 
mean iodine intake from supplements. In our ALSPAC sample, only two women took a kelp 283 
supplement and one took a potassium-iodide supplement; they were excluded from the 284 
analysis. Data on the use of iodine-containing multivitamin supplements from pre-conception 285 
until enrolment (at time of urine sample collection) were available only for a sub-set of our 286 
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Generation R sample (n=381); women who took an iodine-containing supplement (n=345) 287 
were excluded in sensitivity analyses.  288 
 289 
Maternal and pregnancy characteristics  290 
Information on pregnancy characteristics, anthropometrics, socio-demographic and 291 
environmental exposures was collected by means of questionnaires or extracted from 292 
obstetric medical records. Discrete variables were re-categorised, where possible, to facilitate 293 
comparisons between cohorts. Exposure factors in these analyses can be classified into three 294 
groups: (i) maternal factors: maternal age (ALSPAC: at last menstrual period; Generation R, 295 
INMA: at urine collection); pre-pregnancy body mass index (BMI, kg/m2); ethnicity 296 
(ALSPAC: White/non-white; Generation R: Dutch/non-Dutch, where non-Dutch = 297 
Indonesian, Cape Verdian, Moroccan, Dutch Antilles, Surinamese, Turkish, other non-298 
Western, Asian, other Western; INMA: Spanish/non-Spanish, where non-Spanish = Latin 299 
American, European, others); parity (zero, one, two or more); smoking status (never smoked, 300 
smoked initially or until pregnancy was known, continued smoking); and alcohol 301 
consumption during pregnancy (yes/no); (ii) markers of socio-economic status: education 302 
level (ALSPAC: low = no qualification, certificate of secondary education, or vocational; 303 
medium = O level or A level; high = a degree; Generation R: low = no education or primary; 304 
medium = secondary phase 1 and 2; high = higher phase 1 and 2; INMA: low = no education, 305 
unfinished primary, or primary; medium = secondary; high = university degree); monthly net 306 
household income (Generation R: low <€1200, medium = €1200-2200, high >€2200); home 307 
ownership (ALSPAC: owned/mortgaged, private/other rented, council rented); crowding 308 
index (ALSPAC: ≤1 person per room, +1 person per room); family adversity index 309 
[ALSPAC: 18-item measure of hardships during pregnancy [40], categorised into: no 310 
adversities, mild (0-2), severe (≥3) [41]]; life event score (ALSPAC: exposure to stressful 311 
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situations during pregnancy); marital status (ALSPAC: never married, married, other; 312 
Generation R: unmarried/married); and living with father’s child/partner (ALSPAC, INMA: 313 
yes/no); (iii) child factors: child’s sex (male/female).  314 
 315 
Statistical analyses 316 
To study the associations of maternal characteristics and diet with iodine status, we used 317 
UI/Creat as a measure of individual iodine status. UI/Creat was not normally distributed but 318 
right-skewed. To meet parametric-test assumptions, UI/Creat was transformed using the 319 
natural logarithm. Outliers were assessed by visual inspection of box-plots. We assessed non-320 
linearity of the associations of each continuous independent variable with UI/Creat by adding 321 
their squared term to the regression models, and also by plotting each potential determinant 322 
variable against UI/Creat and comparing the fit (R2) of a linear vs. quadratic function through 323 
the data points.  324 
Multiple linear regression models with log-transformed UI/Creat as the dependent 325 
variable were performed for each cohort using two models: Model 1 included maternal and 326 
pregnancy factors, markers of socio-economic status and child’s sex as independent 327 
variables; Model 2 included variables from Model 1 plus dietary intake of food groups.  328 
Analyses of the dietary influences on UI/Creat (Model 2) were also adjusted for 329 
estimated energy intake (kcal/day). Effect estimates (unstandardised B coefficients) for food 330 
groups were expressed per 100 g and also per portion (g). The increase in the geometric mean 331 
of UI/Creat per 100 g and per portion increase in intake and its 95% confidence interval (CI) 332 
were calculated by back-transformation [exponentiation (EXP)] of the effect estimates and 333 
95% CIs from logarithmic scale. The following formulae were used for the back-334 
transformations: Effect estimate per 100 g = EXP (intercept + B*100) – EXP (intercept); 335 
Lower 95% CI = EXP [intercept + (B*100) – (1.96*standard error of estimate (SEE)*100)] 336 
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– EXP (intercept); Upper 95% CI = EXP [intercept + (B*100) + (1.96*SEE*100)] – EXP 337 
(intercept). For calculations per portion size, the multiplication by 100 in the formulae is 338 
replaced with the portion size (g) for each food group accordingly. When calculating the 339 
effect estimates from Model 2, all categorical covariates were set to their reference group and 340 
the continuous covariates gestational week, maternal age, BMI and energy intake were 341 
centred to their means.  342 
We conducted four types of sensitivity analyses: (i) under-reporting: to account for 343 
potential under-reporting of energy intake in Model 2, in all cohorts, we excluded women 344 
with energy intakes below the 5th percentile; (ii) iodine supplements: we adjusted Model 2 for 345 
iodine-supplement use in INMA (as the only cohort with complete iodine-supplement data) 346 
and excluded iodine-supplement-users in Generation R (as data were available only for a sub-347 
set of the sample); (iii) gestational age: as the median gestational week at urine sampling was 348 
later in INMA and Generation R than in ALSPAC, we performed sensitivity analyses to test 349 
the associations with iodine status in the first trimester, using samples collected up to 13 350 
weeks; (iv) covariate creatinine-adjustment method: since age, BMI and ethnicity are known 351 
predictors of urinary creatinine concentration [42] and urinary creatinine can also vary during 352 
gestation [43], this could result in spurious associations of these variables with the ratio of 353 
UI/Creat; we therefore performed sensitivity analyses for these variables (BMI, age, 354 
ethnicity, and gestational age) using Model 1 and 2 with the (natural) log-transformed UIC 355 
(µg/L) unadjusted for creatinine as our dependent variable and added creatinine concentration 356 
as a separate independent variable to the models. This method has been recommended 357 
previously [42] and ensures that UIC is adjusted for dilution by creatinine concentration 358 
while the associations of the other variables with UIC are independent of urinary creatinine.  359 
All analyses were conducted using multiply-imputed data in order to account for 360 
missing data on socio-demographic variables. Multiple imputation was performed using the 361 
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automatic method in SPSS. A total of 20 datasets were generated and analysed using standard 362 
multiple imputation procedures [44]. Detailed information about the imputed variables is 363 
provided in the Electronic Supplementary Material. Missing FFQ data were not imputed, as 364 
diet has a wide inter-person variability hence imputation of dietary data would not be 365 
sufficiently accurate. All statistical analyses were performed with IBM SPSS Statistics 366 
version 24.0 (IBM Corp., Armonk, NY, USA). Values were considered statistically 367 
significant at P<0.05. 368 
 369 
Results  370 
Sample characteristics  371 
After exclusions, the final study population comprised 6566 pregnant women: 2852 from 372 
ALSPAC, 2254 from Generation R, and 1460 from INMA (Fig. 1). Descriptive statistics of 373 
mothers by cohort are shown in Table 1. Maternal age varied across cohorts, with women in 374 
ALSPAC having a lower mean ± standard deviation (SD) age than women in INMA [28.7 375 
(±4.5) vs. 31.4 (±4.1) years, respectively]. Median BMI was within the healthy range in all 376 
cohorts (Table 1). The majority of mothers defined themselves as White in ALSPAC 377 
(98.2%), Spanish in INMA (91.8%), while slightly more than half of the women in 378 
Generation R said they were non-Dutch (51.4%). Most women were nulliparous and non-379 
smokers, with similar proportions between cohorts.  380 
 381 
Iodine status 382 
The median UI/Creat (25-75th percentile) was 121 (81-193) µg/g in women from the UK 383 
(62.8% <150 µg/g), 151 (96-255) µg/g in women from Spain (49.5% <150 µg/g), and 210 384 
(140-303) µg/g in women from the Netherlands (28.8% <150 µg/g) (Table 2). 385 
 386 
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Association with socio-demographic and lifestyle factors 387 
In multivariable models (adjusted Models 1 and 2), gestational week of urine sample, 388 
maternal age, and BMI were associated with UI/Creat in all three cohorts. Gestational week 389 
at urine sampling (≤18 weeks) was positively associated with UI/Creat in ALSPAC 390 
(B=0.051, P<0.0001) but not in the other two cohorts (Table 3). However, in sensitivity 391 
analyses restricted to samples collected up to 13 weeks, there was an association of 392 
gestational week with UI/Creat in all three cohorts (ALSPAC: B=0.029, P<0.001, n=1951; 393 
Generation R: B=0.031, P=0.049, n=1094; INMA: B=0.079, P=0.045, n=747) with a larger 394 
effect size in Generation R and INMA than in the analyses up to 18 weeks. In the sensitivity 395 
analysis using covariate creatinine-adjustment, the results for the association of gestational 396 
week up to 18 weeks with UIC did not substantially differ from those with UI/Creat in 397 
ALSPAC and INMA, while in Generation R the effect size was higher, reaching statistical 398 
significance (Supplemental Table 3). 399 
There was a positive association of maternal age with UI/Creat (ALSPAC: B=0.014, 400 
P<0.0001; Generation R: B=0.018, P<0.0001; INMA: B=0.020, P=0.0001). After further 401 
adjusting for maternal diet and energy intake estimated from the FFQs (Model 2), the effect 402 
size of age was attenuated by 16 - 30 % across cohorts, but remained statistically significant 403 
(Table 3). The positive association with age remained in all cohorts, except in Model 2 for 404 
ALSPAC, when using the covariate creatinine-adjustment method of UIC (Supplemental 405 
Table 3). 406 
There was a negative association of BMI with UI/Creat (ALSPAC: B= -0.013, 407 
P=0.0001; Generation R: B= -0.011, P<0.0001; INMA: B= -0.013, P=0.005), which, after 408 
adjustment for maternal diet and energy intake remained statistically significant (Table 3, 409 
Model 2). However, BMI was not associated with UIC (µg/L) with the covariate creatinine-410 
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adjustment method in Generation R and INMA but remained negatively associated with UIC 411 
in ALSPAC, though with a lower effect size (Supplemental Table 3). 412 
Cohort-specific socio-demographic and lifestyle factors were identified as 413 
determinants of iodine status. In Generation R, maternal ethnicity and smoking were 414 
associated with UI/Creat (Table 3). Compared to the Dutch women, Moroccan, Turkish and 415 
other non-Western women had a higher UI/Creat, whereas Surinamese and those from the 416 
Dutch Antilles had a lower UI/Creat. Some of these effects were attenuated after accounting 417 
for maternal diet in Model 2 (Table 3). Similarly to UI/Creat, UIC (with covariate creatinine-418 
adjustment) also differed by ethnicity; Moroccan, Turkish and other non-Western women still 419 
had a significantly higher UIC than the Dutch, while the UICs of Surinamese and Dutch 420 
Antilles women did not significantly differ from those of the Dutch women (Supplemental 421 
Table 3). Generation R women who reported smoking vs. those who never smoked had a 422 
lower UI/Creat, which remained statistically significant after adjustment for maternal diet 423 
(Table 3, Model 1 and 2). In ALSPAC, family adversity index (severe vs. none; B= -0.100, 424 
P=0.016), and marital status (married vs. never-married; B=0.095, P=0.015) were associated 425 
with UI/Creat, even after adjusting for maternal diet (Table 3). Results for all predictors 426 
included in the multivariable models are presented in Supplemental Table 2. 427 
 428 
Dietary influences on iodine status 429 
As not all women with urinary iodine measurements before 18 weeks had also completed an 430 
FFQ, numbers for these analyses were lower for all cohorts (Fig. 1): ALSPAC (n=2710), 431 
Generation R (n=1580), INMA (n=1446). Descriptive statistics of dietary intakes of food 432 
groups for pregnant women in each cohort are presented in Supplemental Table 4. 433 
“Milk and dairy products” was the only food group positively associated with 434 
UI/Creat in all three cohorts: ALSPAC (B=3.73, P<0.0001); Generation R (B=2.34, 435 
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P=0.001); INMA (B=6.92, P=0.002) (Supplemental Table 5). Based on the fully-adjusted 436 
models, one-portion increase in consumption of milk and dairy products (e.g., a glass of milk, 437 
200 g) [45] was associated with a 5-14 µg/g increase in the geometric mean of UI/Creat 438 
(Table 4). Intake of “fish and shellfish” was positively associated with UI/Creat in pregnant 439 
women in Spain (INMA) and the UK (ALSPAC), though the effect size per 100 g was more 440 
than five times larger in INMA women (B=28.04, P=0.029 vs. B=5.10, P=0.017).  441 
Cohort-specific dietary determinants were also identified (Table 4). In ALSPAC, 442 
consumption of fruit (P=0.012), cakes and confectionery (P=0.028) were positively 443 
associated with UI/Creat. Intake of cereals and cereal products (P<0.0001), eggs (P=0.0001), 444 
nuts and seeds (P=0.001), and added fat (P=0.022) were all positively associated with 445 
UI/Creat in Generation R. Higher salt intake (including iodised salt) (per 1 g) was associated 446 
with higher UI/Creat (P=0.003), while increasing meat intake was associated with lower 447 
UI/Creat (P=0.002) in INMA.  448 
Excluding women with extremely low energy intakes (< 5th percentile) did not 449 
considerably change our results, except for small changes in INMA where the association 450 
between fish intake and UI/Creat was borderline significant but the effect size remained 451 
relatively unchanged (data not shown). In INMA, mean daily iodine-supplement intake was 452 
an important determinant of UI/Creat (Standardised B=0.235, P<0.0001). Adjusting for 453 
iodine-supplement use in INMA attenuated the result for maternal age (B=0.012, P=0.018) 454 
but did not change the rest of the results substantially (data not shown). In Generation R, the 455 
exclusion of iodine-supplement users resulted in higher effect estimates for some ethnic 456 
groups (e.g., Moroccan, Turkish and other Western); the associations between intake of non-457 
alcoholic and alcoholic beverages and UI/Creat reached statistical significance but the effect 458 
sizes remained unchanged; the rest of the results remained relatively unchanged (data not 459 
shown). 460 
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 461 
Discussion 462 
In this study of pregnant women, several dietary (milk and dairy products) and maternal 463 
factors (maternal age, BMI, gestational week) were associated with UI/Creat across all 464 
cohorts in adjusted models. Furthermore, important cohort-specific dietary determinants were 465 
identified, such as fish intake in ALSPAC (UK), egg and cereal/cereal product intake in 466 
Generation R (Netherlands), and fish, salt, and meat intake in INMA (Spain).  467 
The population of pregnant women from the Netherlands was iodine-sufficient, while 468 
populations from the UK and Spain were mildly-to-moderately deficient. It should be noted 469 
that the ALSPAC median-UIC value, although from samples that are nearly 25 years old, is 470 
almost identical to the UK value from the 2017 Global Scorecard for Iodine Nutrition in 471 
pregnant women i.e., 95 µg/L vs. 99 µg/L [15].  472 
The differences in iodine status between the countries may be partly explained by 473 
differing use of iodised salt. The iodised salt penetration rate in households and the food 474 
industry (e.g., bread-making) in the Netherlands has been estimated as 60% and 70%, 475 
respectively, while a 16% penetration rate has been reported in Spanish households [46]. By 476 
contrast, iodisation of salt was never common in the UK [47], and even nowadays its 477 
availability is very limited (21.5%); furthermore, the iodine concentration of the major UK 478 
brand is low [48].  479 
 480 
Association with socio-demographic and lifestyle factors 481 
Gestational week of urine samples was positively associated with a UI/Creat in ALSPAC but 482 
not in the other cohorts. This may be because ALSPAC samples were collected at an earlier 483 
gestational age than in the other cohorts; if the greatest increase in urinary iodine excretion is 484 
in the first weeks of pregnancy, the effect of gestational age may be attenuated in later 485 
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samples (i.e., up to 18 weeks as in our study). Indeed in sensitivity analyses, when we 486 
restricted analysis to samples collected up to 13 weeks, the effect size was higher in the other 487 
two cohorts. The positive association between gestational week of urine sample with 488 
UI/Creat in early pregnancy could be attributed to an increase in glomerular filtration rate and 489 
subsequent renal iodine loss in early pregnancy [49, 50], though data are conflicting as 490 
studies report both an increase and a decrease in the UI/Creat  [51–54]. As urinary iodine 491 
excretion in early vs. late pregnancy stages might be higher as a result of increased renal 492 
clearance of iodine, using early measurement to assess status might overestimate true intake 493 
[55]. Creatinine clearance has also been shown to vary during gestation [43], which could 494 
have biased our results when using UI/Creat. However, gestational week was also positively 495 
associated with UIC (µg/L) alone when including creatinine separately in the model.  496 
In all three cohorts, BMI was negatively associated with UI/Creat. In a study in non-497 
pregnant adults [56], creatinine clearance was positively associated with BMI, independent of 498 
adiposity, and a positive association with lean thigh-tissue area was reported; this suggests 499 
that the association of creatinine with BMI might be explained by lean body mass. The 500 
negative association between BMI and UI/Creat that we report may therefore be partly 501 
explained by the use of creatinine adjustment and may highlight potential issues with the use 502 
of this measure of iodine status [42, 57]. Indeed in sensitivity analysis, we did not find an 503 
association of BMI with UIC alone in two of the cohorts when we adjusted for creatinine by 504 
including it as a covariate in the model instead of using the ratio of UI/Creat.  505 
There was a positive association of maternal age with UI/Creat in all cohorts. Age 506 
was still significantly associated with UI/Creat after adjustment for dietary intake though the 507 
effect size was attenuated; it was further reduced when iodine-supplement use in INMA was 508 
accounted for, suggesting that some of the effect of age could be explained by diet and 509 
supplement use in older women. Similarly to BMI, age is a known predictor of urinary 510 
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creatinine [42]. However, in sensitivity analysis when adjusting for creatinine separately in 511 
the model, unlike BMI, age remained positively associated with UIC but with a lower effect 512 
size.    513 
The iodine status of pregnant women from the Netherlands varied by ethnic origin, 514 
with higher iodine status in Moroccan, Turkish and other non-Western women, and lower 515 
iodine status in Surinamese and Dutch Antilles women, even after adjusting for socio-516 
demographic factors. Variation in diet may partially explain these differences as some of the 517 
effect estimates were attenuated when adjusting for dietary intake. Alternatively, there may 518 
be genetic variability in iodine or creatinine clearance [42, 58]. Indeed, we found that when 519 
using UIC and adjusting for urinary creatinine separately in the model, UIC varied similarly 520 
to UI/Creat between the ethnic groups though some of  the associations were attenuated and 521 
were no longer significant (e.g., for Surinamese and Dutch Antilles women). It should be 522 
noted that numbers in some of these ethnic-group categories were relatively small (n<100). 523 
Ethnicity was not significantly associated with iodine status in ALSPAC or INMA, but this 524 
may reflect the small sample sizes of other ethnic groups in these cohorts. Ethnic differences 525 
in iodine status could help to identify subgroups at high-risk for iodine insufficiency; in 526 
countries with a large proportion of diverse ethnic groups, culturally-specific approaches to 527 
improve dietary adequacy may be more suitable than a single solution for the whole 528 
population. 529 
 530 
Dietary influences on iodine status 531 
The only food group that was positively associated with UI/Creat in all three cohorts was 532 
“milk and dairy products”, demonstrating their significant role as an important dietary 533 
determinant of iodine status in pregnancy. This finding is consistent with the results of other 534 
23 
 
studies in European pregnant women, i.e., Norway [59, 60], Iceland [61], Italy [62], Spain 535 
[63], and the UK [52, 64], as well as studies of pregnant women in Australia [65].  536 
Based on our model, a portion of “milk and dairy products” equivalent to a glass of 537 
milk (200 g) was associated with 5 to 14 µg/g increase in UI/Creat across cohorts. The effect 538 
sizes for milk differed between cohorts; the highest effect size was in Spain, while the lowest 539 
was in the Netherlands. This is in line with the milk-iodine concentration in each country 540 
[i.e., ~26 µg in Spain [66],  ~15 µg in the Netherlands [67], and 15 µg in the UK in 541 
1990/1991 [68]]. The results might be different if repeated now as the iodine concentration in 542 
UK milk is higher than estimated when ALSPAC women were recruited in 1990/1991, i.e. 543 
427 vs. 150 µg/kg [68, 69].   544 
Consumption of eggs and fish were positively associated with UI/Creat, though not 545 
consistently across the cohorts; the association with egg intake was statistically significant 546 
only in the Netherlands, while intake of fish and shellfish was associated with UI/Creat only 547 
in Spain and the UK. The effect size for eggs was higher than that expected, given their 548 
iodine content, but similar to values reported previously [60]. These higher values may reflect 549 
the consumption of eggs with salt in the Netherlands, which is likely to be iodised. An 550 
average portion of fish (120 g) was associated with some 6 to 34 µg/g increase in UI/Creat, 551 
across cohorts. Variation in the effect-size could partly reflect the variability in average fish 552 
consumption, particularly of white fish, which is a good iodine source [70] (e.g., pregnant 553 
women in Spain consumed a higher amount of white fish daily than did women in the UK). 554 
The wide CIs around the estimates probably relate to the variability in fish-iodine 555 
concentration [14] [i.e., the proportion of oily fish in the food group has a much lower iodine 556 
concentration [70]] and to the irregular nature of fish consumption which may not be 557 
captured by a spot-UI/Creat.  558 
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Consumption of cereals and cereal products was a statistically significant determinant 559 
of UI/Creat only in the Netherlands; this association is probably driven by consumption of 560 
bread which is made with iodised salt in the Netherlands [71], whereas without iodised salt, 561 
bread has a low iodine concentration and was not found to be a predictor of iodine status in 562 
the UK or Spanish cohorts.  Intake of iodised table salt was measured only in pregnant 563 
women from Spain; 1 g of salt was associated with around 32 µg/g increase in UI/Creat. Both 564 
of these results suggest that iodised salt consumed either discretionarily (e.g., as table salt in 565 
Spain), or as part of processed foods (e.g., in bread in the Netherlands) is an important dietary 566 
determinant of iodine status. We observed the highest UI/Creat in the Netherlands, followed 567 
by Spain, and the lowest in the UK, suggesting that iodised-salt use might be a key dietary 568 
factor with large influence on iodine status.  569 
Surprisingly, meat intake was negatively associated with UI/Creat in the Spanish 570 
cohort, even after controlling for socio-demographic variables. Higher urinary creatinine 571 
concentrations have been reported in individuals with a high-meat diet, which may account 572 
for the lower ratio [72, 73].  573 
Some of our other food-group associations are difficult to explain and may be chance 574 
findings e.g. the positive association with fruit, and cakes/confectionary in the UK. However, 575 
fruit intake was also associated with urinary iodine excretion in Norwegian pregnant women 576 
[59] and the finding might warrant further investigation.   577 
Although we have observed significant increases in UI/Creat, the effect sizes were 578 
relatively small and the total explained variance in UI/Creat (R2) was low. This is probably 579 
explained by the large day-to-day variability in iodine intake which cannot be captured in a 580 
single spot-urine sample and the measurement errors of dietary assessment methods in 581 
capturing habitual iodine intake. Moreover, as a result of the physiological changes occurring 582 
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during gestation (e.g., increased renal iodine clearance), pregnancy may not represent a 583 
steady state of iodine metabolism (intake vs. excretion) [10]. 584 
 585 
Strengths and limitations 586 
Strengths of our study include the large sample size, the inclusion of pregnant women from 587 
three geographically and culturally different populations. Furthermore, we explored 588 
associations with the entire range of food groups, rather than focusing on a few groups or 589 
isolated foods as in previous studies [62, 63]. However, our study also has a number of 590 
limitations. Firstly, the use of an FFQ for measuring diet and the use of spot-urine samples 591 
for estimating individual iodine intake have their methodological disadvantages [24–26, 74]. 592 
Although we only had spot-urine samples which might not reflect individual iodine intake or 593 
status, we used UI/Creat which has been shown as a valid alternative to the 24-hour urinary 594 
iodine excretion when used in homogenous population groups [75]. Although urinary iodine 595 
concentration was measured in three different laboratories using different assays, each 596 
laboratory ensured accuracy by use of certified reference materials. Exploring associations 597 
between data from an FFQ and spot-UI/Creat can also be problematic, as an FFQ is designed 598 
to measure habitual diet [76], whereas a spot-urine sample reflects iodine intake in the last 599 
24-48 hours [11]; this may be reflected in the more consistent association between UI/Creat 600 
and intake of daily food items (e.g., milk) than those infrequently consumed (e.g., fish). 601 
However, our large cohort sample size would have helped to overcome this limitation to 602 
some extent. Secondly, it should be noted that in ALSPAC there was a time difference in the 603 
administration of the FFQ (at 32 weeks) and urine-sample collection (≤18 weeks), hence the 604 
FFQ might not reflect diet during early pregnancy. Thirdly, although we harmonised the 605 
classification of foods into food groups, there were some differences in the foods included in 606 
each group which may explain variation in effect sizes between cohorts (i.e., in ALSPAC the 607 
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dairy food group included milk and cheese, while in INMA and Generation R, ice cream, 608 
yoghurt, cream were also included). Fourthly, we had incomplete, or no, data on iodine 609 
supplement use in two of the cohorts (Generation R and ALSPAC), which could be an 610 
important determinant that we were unable to evaluate; however this is unlikely to be a 611 
limitation in ALSPAC as it is unlikely that women would have taken an iodine-containing 612 
supplement in the early 1990s. Lastly, we measured urinary iodine only in women with 613 
available child IQ data in two of the cohorts which might have created bias.  614 
 615 
Conclusions 616 
Various maternal characteristics and dietary habits were associated with UI/Creat in 617 
pregnancy, some of which were population-specific. For that reason, universal interventions 618 
and dietary recommendations to improve the iodine intake of pregnant women might not be 619 
appropriate; a country-specific approach needs to be adopted. Between countries, but also 620 
within countries with a large proportion of different ethnic groups, culturally-specific 621 
recommendations are probably necessary. Achieving and maintaining iodine sufficiency in 622 
populations requires monitoring dietary determinants of iodine status so that appropriate 623 
action can be taken, where necessary.  624 
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Table 1 Descriptive statistics a of the study population by cohort 904 
Sample characteristics 
ALSPAC                                     
(n=2852) 
Generation R          
(n=2254) 
INMA                
(n=1460) 
Maternal factors    
Age b,c (years), mean (±SD) 28.7 (±4.5) 29.9 (±5.0) 31.4 (±4.1) 
Pre-pregnancy BMI (kg/m2), 
median (IQRs) c 22.3 (20.5 - 24.6) 23.5 (21.5 - 26.4) 22.5 (20.8 - 25.0) 
Ethnicity d, n (%)    
    Reference group 2800 (98.2) 1095 (48.6) 1340 (91.8) 
    Non-white 52 (1.8) N/A N/A 
    Non-Dutch N/A 1159 (51.4) e N/A 
    Non-Spanish N/A N/A 120 (8.2) 
Parity c, n (%)    
    0 1354 (47.5) 1279 (56.7) 806 (55.2) 
    1 965 (33.8) 665 (29.5) 544 (37.3) 
    ≥ 2 533 (18.7) 310 (13.8) 110 (7.5) 
Smoking status, n (%)    
    Never smoked 2169 (76.1) 1671 (74.2) 1020 (69.9) 
    Stopped smoking 333 (11.7) 211 (9.3) 187 (12.8) 
    Continued smoking 350 (12.2) 372 (16.5) 253 (17.3) 
Alcohol consumption, n (%)    
    No 1350 (47.4) 1458 (64.7) 1330 (91.1) 
    Yes 1502 (52.6) 796 (35.3) 130 (8.9) 
Markers of socio-economic status 
Education level, n (%)    
    Low 576 (20.2) 247 (11.0) 337 (23.1) 
    Medium 1780 (62.4) 995 (44.1) 581(39.8) 
    High 496 (17.4) 1012 (44.9) 542 (37.1) 
Net household income  
(€ per month), n (%)    
    Low < €1200 N/A 492 (21.8) N/A 
    Medium €1200-2200 N/A 597 (26.5) N/A 
    High > €2200 N/A 1165 (51.7) N/A 
Home ownership, n (%)    
    Owned/mortgaged 2425 (85.0) N/A N/A 
    Private/other rented 236 (8.3) N/A N/A 
    Council rented 191 (6.7) N/A N/A 
Crowding index, n (%)    
    ≤ 1 person per room 2747 (96.3) N/A N/A 
    + 1 person per room 105 (3.7) N/A N/A 
Family adversity index, n (%)    
    None 0 1395 (48.9) N/A N/A 
    Mild 1-2 1124 (39.4) N/A N/A 
    Severe > 3 333 (11.7) N/A N/A 
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Table 1 Descriptive statistics a of the study population by cohort (continued) 
Sample characteristics  
ALSPAC         
(n=2852) 
Generation R 
(n=2254) 
INMA                
(n=1460) 
Markers of socio-economic status 
Life event score, median (IQRs) 3.0 (2.0 - 5.0) N/A N/A 
Marital status, n (%)    
    Never-married 355 (12.5) 1136 (50.4) N/A 
    Married 2357 (82.6) 1118 (49.6) N/A 
    Other f 140 (4.9) N/A N/A 
Living with a partner, n (%)    
    Yes 2720 (95.4) N/A 1445 (99.0) 
    No 132 (4.6) N/A 15 (1.0) 
Child factors    
Child’s sex c, n (%)    
    Male 1405 (49.3) 1147 (50.9) 737 (50.5) 
    Female 1447 (50.7) 1107 (49.1) 723 (49.5) 
a Data presented as mean (±SD) for continuous normally distributed variables, median (IQRs) for 905 
continuous non-normally distributed variables and n (%) for categorical variables.  906 
b Maternal age at urine sample collection, except in ALSPAC (age at last menstrual period). 907 
c Data were not imputed, due to no missing values for age (in ALSPAC, Generation R), pre-pregnancy 908 
BMI (INMA), parity (Generation R) and child's sex (ALSPAC). The rest of the data are shown after 909 
imputation of the missing values (see methods).  910 
d ALSPAC (Reference group=White); Generation R (Reference group=Dutch, Non-Dutch=Indonesian, 911 
Cape Verdian, Moroccan, Dutch Antilles, Surinamese, Turkish, Other non-western, Asian, or Other 912 
western, see Table 3); INMA (Reference group=Spanish, Non-Spanish=Latin American, European, or 913 
Others). 914 
e Non-Dutch group in Generation R presented in detail in Table 3. 915 
f ALSPAC (Other=widowed, divorced, or separated). 916 
Abbreviations: BMI, body mass index; IQRs, interquartile ranges; N/A, data not available or not 917 
applicable; SD, standard deviation. 918 
41 
 
Table 2 Urinary iodine status in early pregnancy (≤ 18 gestational weeks) expressed as UIC, UI/Creat and proportion of mothers with UI/Creat 919 
below 150 µg/g 920 
 
ALSPAC 
(n=2852) 
 Generation R 
(n=2254) 
 INMA 
(n=1460) 
Gestational age at urine sampling, weeks a   11.0 (8.0 - 15.0)    13.1 (12.1 - 14.6)   13.0 (12.4 - 13.9) 
Urinary iodine concentration (UIC), µg/L a      95 (56 - 151)     165 (94 - 277)      130 (76 - 219) 
Iodine-to-creatinine ratio (UI/Creat), µg/g a    121 (81 - 193)     210 (140 - 303)      151 (96 - 255) 
UI/Creat < 150 µg/g, n (%)  1792 (62.8)     650 (28.8)      723 (49.5) 
a Data presented as median (25th - 75th percentiles). 921 
Abbreviations: UI/Creat, urinary iodine-to-creatinine ratio; UIC, urinary iodine concentration.922 
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Table 3 Determinants a of urinary iodine-to-creatinine ratio measured at ≤ 18 gestational weeks, statistically significant in at least one cohort 923 
 
ALSPAC (n=2852) 
 
Generation R (n=2254)  INMA (n=1460) 
 Adjusted Model 1 
b Adjusted Model 2 c   Adjusted Model 1 b Adjusted Model 2 c   Adjusted Model 1 b Adjusted Model 2 c 
Determinants n B P n B P  n B P n B P  n B P n B P 
Gestational age at urine 
sampling, weeks 
2852 0.051 <0.001 2710 0.052 <0.001   2254 0.007 0.300 1580 0.011 0.133   1460 0.004 0.755 1446 -0.009 0.513 
Age d, years 2852 0.014 <0.001 2710 0.010 0.002   2254 0.018 <0.001 1580 0.015 <0.001   1460 0.020 <0.001 1446 0.014 0.008 
Pre-pregnancy BMI, 
kg/m2 
2852 -0.013 <0.001 2710 -0.012 <0.001   2254 -0.011 <0.001 1580 -0.013 <0.001   1460 -0.013 0.005 1446 -0.010 0.033 
Family adversity index                                         
    None 0 1395 Ref.   1334 Ref.     N/A . . . . .   N/A . . . . . 
    Mild 1-2 1124 -0.007 0.765 1069 -0.003 0.906   N/A . . . . .   N/A . . . . . 
    Severe > 3 333 -0.100 0.016 307 -0.086 0.046   N/A . . . . .   N/A . . . . . 
Marital status                                         
    Never-married 355 Ref.   320 Ref.     1136 Ref.    825 Ref.     N/A . . . . . 
    Married 2357 0.095 0.015 2269 0.119 0.003   1118 0.030 0.285 755 0.044 0.168   N/A . . . . . 
    Other e 140 0.028 0.666 121 0.051 0.447   N/A . . . . .   N/A . . . . . 
Ethnicity f                                         
    Reference group 2800 Ref.   2674 Ref.      1095 Ref.   930 Ref.     1340 Ref.   1328 Ref.   
    Non-white 52 -0.018 0.851 36 0.043 0.676   N/A . . . . .   N/A . . . . . 
    Non-Dutch: N/A . . . . .                 N/A . . . . . 
    - Indonesian N/A . . . . .   72 -0.047 0.494 58 -0.081 0.286   N/A . . . . . 
    - Cape Verdian N/A . . . . .   87 -0.013 0.848 41 0.065 0.502   N/A . . . . . 
    - Moroccan N/A . . . . .   165 0.255 <0.001 72 0.182 0.028   N/A . . . . . 
    - Dutch Antilles N/A . . . . .   65 -0.174 0.025 37 -0.225 0.031   N/A . . . . . 
    - Surinamese N/A . . . . .   196 -0.115 0.017 111 -0.160 0.014   N/A . . . . . 
    - Turkish N/A . . . . .   226 0.391 <0.001 103 0.360 <0.001   N/A . . . . . 
    - Other, non-western N/A . . . . .   107 0.157 0.011 53 0.125 0.137   N/A . . . . . 
    - Asian N/A . . . . .   32 0.091 0.383 19 0.028 0.835   N/A . . . . . 
    - Other, western N/A . . . . .   209 0.052 0.228 156 0.062 0.213   N/A . . . . . 
    Non-Spanish N/A . . . . .   N/A . . . . .   120 -0.016 0.810 118 -0.003 0.961 
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Table 3 Determinants a of urinary iodine-to-creatinine ratio measured at ≤ 18 gestational weeks, statistically significant in at least one cohort (continued) 
 
ALSPAC (n=2852)   Generation R (n=2254)   INMA (n=1460) 
 Adjusted Model 1 b Adjusted Model 2 c  Adjusted Model 1 b Adjusted Model 2 c  Adjusted Model 1 b Adjusted Model 2 c 
Determinants n B P n B P  n B P n B P  n B P n B P 
Smoking status                     
    Never smoked 2169 Ref.   2077 Ref.     1671 Ref.   1202 Ref.     1020 Ref.   1011 Ref.   
    Stopped smoking 333 -0.003 0.943 312 -0.010 0.797   211 -0.093 0.035 147 -0.121 0.020   187 -0.060 0.296 186 -0.060 0.287 
    Continued smoking 350 0.018 0.620 321 0.060 0.116   372 -0.008 0.831 231 0.049 0.296   253 -0.001 0.990 249 0.020 0.707 
a Effect estimates (B=unstandardised regression coefficient) and P-values from multiple linear regression models performed for each cohort with (natural) log-transformed iodine-924 
to-creatinine ratio (UI/Creat) as the dependent variable and maternal characteristics and dietary intakes as independent variables (for full models, see footnotes b and c). Reported 925 
B coefficients represent the change in the mean (natural) log of UI/Creat per unit increase in the continuous independent variables and for each category compared to the reference 926 
for the categorical independent variables.  927 
b Adjusted Model 1 (adjusted for maternal and pregnancy characteristics); ALSPAC (R2=0.123, P < 0.0001): gestational age (weeks), age (years), pre-pregnancy BMI (kg/m2), 928 
ethnicity, parity, smoking status, alcohol consumption, education, home ownership, crowding index, family adversity index, life event score, marital status and child’s sex; 929 
Generation R (R2=0.086, P < 0.0001): gestational age (weeks), age (years), pre-pregnancy BMI (kg/m2), ethnicity, parity, smoking status, alcohol consumption, education, net 930 
household income, marital status and child’s sex; INMA (R2=0.021, P < 0.0001): gestational age (weeks), age (years), pre-pregnancy BMI (kg/m2), ethnicity, parity, smoking status, 931 
alcohol consumption, education, living with a partner and child’s sex . 932 
c Adjusted Model 2 (adjusted for maternal and pregnancy characteristics + dietary intakes); ALSPAC (R2=0.147, P < 0.0001): Model 1 + energy intake (kcal/day) + intake of 933 
vegetables (g/day), fruit (g/day), nuts and seeds (g/day), potatoes (g/day), legumes (g/day), cereals and cereal products (g/day), cakes, confectionery and added sugar (g/day), added 934 
fats (g/day), milk and dairy products (g/day), meat and meat products (g/day), eggs (g/day), fish and shellfish (g/day), processed and fried foods (g/day), non-alcoholic beverages 935 
(g/day), miscellaneous (g/day); Generation R (R2=0.091, P < 0.0001): Model 1 + energy intake (kcal/day) + intake of vegetables (g/day), fruit (g/day), nuts and seeds (g/day), 936 
potatoes (g/day), legumes (g/day), cereals and cereal products (g/day), cakes, confectionery and added sugar (g/day), added fats (g/day), milk and dairy products (g/day), meat and 937 
meat products (g/day), eggs (g/day), fish and shellfish (g/day), condiments and seasoning (g/day), processed and fried foods (g/day), non-alcoholic beverages (g/day), alcoholic 938 
beverages (g/day), miscellaneous (g/day); INMA (R2=0.060, P < 0.0001): Model 1 + energy intake (kcal/day) + intake of vegetables (g/day), fruit (g/day), nuts and seeds (g/day), 939 
potatoes (g/day), legumes (g/day), cereals and cereal products (g/day), cakes, confectionery and added sugar (g/day), added fats (g/day), milk and dairy products (g/day), meat and 940 
meat products (g/day), eggs (g/day), fish and shellfish (g/day), condiments and seasoning (e.g., salt) (g/day), processed and fried foods (g/day), non-alcoholic beverages (g/day), 941 
alcoholic beverages (g/day). 942 
d Maternal age at urine sample collection, except in ALSPAC (age at last menstrual period). 943 
e ALSPAC (Other=widowed, divorced, or separated). 944 
f ALSPAC (Reference group=White); Generation R (Reference group=Dutch, Non-Dutch=Indonesian, Cape Verdian, Moroccan, Dutch Antilles, Surinamese, Turkish, Other non-945 
western, Asian, or Other western); INMA (Reference group=Spanish, Non-Spanish=Latin American, European, or Others). 946 
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Abbreviations: BMI, body mass index; N/A, data not available or not applicable; Ref, reference category; UI/Creat, urinary iodine-to-creatinine ratio. 947 
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Table 4 Multivariable associations of food group intakes estimated from FFQ (per portion size, g) a with urinary iodine-to-creatinine ratio 948 
measured at ≤ 18 gestational weeks, statistically significant in at least one cohort 949 
     ALSPAC (n=2710)  Generation R (n=1580)  INMA (n=1446) 
Food group 
Standard 
portion (g) a Description a B (95% CI) b P c  B (95% CI) 
b P d  B (95% CI) 
b P e 
Fruit 80 g a portion '5-a-day' 2.22 (0.47, 4.03) 0.012   0.90 (-0.90, 2.75) 0.328   -3.51 (-7.16, 0.20) 0.064 
Nuts and seeds 30 g a handful 5.08 (-0.63, 11.53) 0.083   12.92 (4.83, 21.73) 0.001   18.63 (-10.61, 52.17) 0.223 
Cereals and cereal 
products 
36 g 
a medium slice of 
bread 
0.51 (-0.33, 1.36) 0.238   4.25 (2.23, 6.31) <0.001   0.07 (-5.12, 5.40) 0.978 
Cakes, confectionery 
and added sugar 
50 g a chocolate bar 2.39 (0.25, 4.63) 0.028   2.64 (-1.13, 6.57) 0.172   -9.19 (-22.95, 5.59) 0.217 
Added fats 10 g 
spread on a slice of 
bread 
1.12 (-0.14, 2.41) 0.082   2.70 (0.39, 5.08) 0.022   -4.19 (-11.03, 2.89) 0.243 
Milk and dairy 
products 
200 g a glass of milk 7.77 (5.65, 9.99) <0.001   4.74 (2.01, 7.56) 0.001   14.07 (5.07, 23.45) 0.002 
Meat and meat 
products 
130 g 
a medium portion 
chicken breast 
1.65 (-2.96, 6.78) 0.497   3.75 (-5.35, 13.87) 0.433   -41.48 (-63.44, -16.20) 0.002 
Eggs 50 g an average egg 2.64 (-0.60, 6.12) 0.112   28.10 (12.27, 46.47) <0.001   39.69 (-6.67, 96.68) 0.099 
Fish and shellfish 120 g a medium cod fillet 6.18 (1.07, 11.87) 0.016   2.42 (-19.04, 30.69) 0.845   34.08 (3.28, 69.37) 0.029 
Condiments and 
seasoning (e.g., salt) f 
5 g 
a level teaspoon 
(WHO) g 
N/A .   1.34 (-1.50, 4.29) 0.359   214.41 (56.88, 465.35) 0.003 
a Portion sizes are based on Food Standard Agency (1998) Food Portion Sizes (3ed.) London: TSO. 950 
b Effect estimates (B=unstandardised regression coefficient) represent the actual change in the geometric mean of UI/Creat (µg/g) associated with a portion size 951 
increase in intake of a food group. B coefficients and their 95% CIs are calculated by back-transformation from logarithmic scale (see methods). Values are 952 
adjusted for dietary intake of other food groups, energy intake and other potential confounders (for full models, see Table 3, footnote c). When calculating the 953 
B coefficients all categorical covariates were set to their reference group and the continuous covariates gestational age, maternal age, pre-pregnancy BMI and 954 
energy intake were centred to their means. 955 
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c P-value adjusted for energy (kcal/day) + gestational age (weeks), age (years), pre-pregnancy BMI (kg/m2), ethnicity, parity, smoking status, alcohol 956 
consumption, education, home ownership, crowding index, family adversity index, life event score, marital status and child’s sex (R2=0.147, P < 0.0001). 957 
d P-values adjusted for energy (kcal/day) + gestational age (weeks), age (years), pre-pregnancy BMI (kg/m2), ethnicity, parity, smoking status, alcohol 958 
consumption, education, net household income, marital status and child’s sex  (R2=0.091, P < 0.0001). 959 
e P-values adjusted for energy (kcal/day) + gestational age (weeks), age (years), pre-pregnancy BMI (kg/m2), ethnicity, parity, smoking status, alcohol 960 
consumption, education, living with a partner and child’s sex  (R2=0.060, P < 0.0001). 961 
f In INMA this food group also includes iodised salt. Separate information about the consumption of table salt and use of iodine-fortified table salt was collected 962 
only in the INMA cohort. 963 
g Maximum daily salt intake, as recommended by WHO (5 g/day salt, or 2 g/day Sodium). 964 
Abbreviations: BMI, body mass index; 95% CI, confidence interval; FFQ, food frequency questionnaire; N/A, data not available; UI/Creat, urinary iodine-to-965 
creatinine; WHO, World Health Organisation. 966 
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 967 
Fig. 1 Flow chart of the study population selection 968 
a Urine samples with UIC > 500 µg/L or UI/Creat > 700 µg/g were excluded only from the ALSPAC 969 
cohort, as there was a concern about contamination by the use of iodine-containing test strips (see 970 
Enrolled during 
pregnancy 
Total N=25571 
ALSPAC (n=14541) 
Generation R (n=8880) 
INMA (n=2150) 
Data unavailable:  
Urinary iodine and creatinine concentration data 
unavailable 
Total N=17762 
ALSPAC (n=11036)  
Generation R (n=6468)  
INMA (n=258) UI/Creat measured 
Total N=7809 
ALSPAC (n=3505) 
Generation R (n=2412) 
INMA (n=1892) 
UI/Creat ≤ 18 weeks 
Total N=6566 
ALSPAC (n=2852) 
Generation R (n=2254) 
INMA (n=1460) 
UI/Creat ≤ 18 weeks  
+ FFQ data 
Total N=5736 
ALSPAC (n=2710) 
Generation R (n=1580) 
INMA (n=1446) 
Exclusions:  
IVF Total N=12 
(ALSPAC, n=0; Generation R, n=12; INMA, n=0) 
Multiple pregnancy Total N=29 
 (ALSPAC, n=0; Generation R, n=29; INMA, 
n=0) 
 Thyroid disease and/or thyroid-related medication 
use Total N=140 
(ALSPAC, n=21; Generation R, n=34; INMA, 
n=85)  
Contaminated samples a Total N=362 
(ALSPAC: UIC > 500 µg/L or UI/Creat > 700 
µg/g, n=362; Generation R, N/A; INMA, N/A) 
UI/Creat available 
Total N=7269 
ALSPAC (n=3122) 
Generation R (n=2340) 
INMA (n=1807) 
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methods). There was no such concern in Generation R and INMA, therefore the exclusion criteria was 971 
not applicable to urine samples from these two cohorts.  972 
Abbreviations: FFQ, food frequency questionnaire; IVF, in-vitro fertilisation; N/A, not applicable; 973 
UI/Creat, urinary iodine-to-creatinine ratio; UIC, urinary iodine concentration. 974 
